• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Isothermal Nucleic Acid Amplification Technologies Market 2014-2018 - Product Image

Global Isothermal Nucleic Acid Amplification Technologies Market 2014-2018

  • Published: February 2014
  • Region: Global
  • 74 pages
  • TechNavio

FEATURED COMPANIES

  • Alere Inc.
  • Axxin Pvt Ltd.
  • bioMerieux S.A.
  • Eiken Chemical Co. Ltd.
  • Hologic Inc.
  • Meridian Bioscience Inc.
  • MORE

The analysts forecast the Global Isothermal Nucleic Acid Amplification Technologies market will grow at a CAGR of 17.49 percent over the period 2013-2018. One of the key factors contributing to this market growth is the technological advances being made in this domain. The Global Isothermal Nucleic Acid Amplification Technologies market has also been witnessing an increase in the miniaturization of nucleic acid-based diagnostics. However, the tough competition from PCR-based diagnostics could pose a challenge to the growth of this market.

The report, Global Isothermal Nucleic Acid Amplification Technologies Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the EMEA region, and the APAC region; it also covers the Global Isothermal Nucleic Acid Amplification Technologies market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space are Becton, Dickson and Co., bioMerieux S.A., Hologic Inc., Novartis International AG., and Quidel Corp.

The other vendors mentioned READ MORE >

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Application
07.1.1 Infectious Disease Diagnostics
07.1.2 Blood Screening
07.1.3 Laboratory Research
07.1.4 Cancer Research
07.2 Global INAAT Market for Infectious Disease Diagnostics
07.2.1 Market Size and Forecast
07.3 Global INAAT Market for Blood Screening
07.3.1 Market Size and Forecast
07.4 Global INAAT Market for Laboratory Research
07.4.1 Market Size and Forecast
07.5 Global INAAT Market for Cancer Research
07.5.1 Market Size and Forecast
08. Market Segmentation by Technology
08.1.1 NASBA
08.1.2 LAMP
08.1.3 SDA
08.1.4 TMA
08.1.5 SPIA
08.1.6 HDA
08.1.7 Others
09. COMPARATIVE ANALYSIS OF TOP ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGIES
10. Geographical Segmentation
10.1 Isothermal Nucleic Acid Amplification Technologies Market in the Americas
10.1.1 Market Size and Forecast
10.2 Isothermal Nucleic Acid Amplification Technologies Market in the EMEA Region
10.2.1 Market Size and Forecast
10.3 Isothermal Nucleic Acid Amplification Technologies Market in the APAC Region
10.3.1 Market Size and Forecast
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Hologic Inc.
19.1.1 Business Overview
19.1.2 Business Segmentation
19.1.3 Key Information
19.1.4 SWOT Analysis
19.2 bioMérieux S.A.
19.2.1 Business Overview
19.2.2 Key Information
19.2.3 SWOT Analysis
19.3 Novartis International AG
19.3.1 Business Overview
19.3.2 Business Segmentation
19.3.3 Key Information
19.3.4 SWOT Analysis
19.4 Quidel Corp.
19.4.1 Business Overview
19.4.2 Key Information
19.4.3 SWOT Analysis
19.5 Becton, Dickinson and Co.
19.5.1 Business Overview
19.5.2 Business Segmentation
19.5.3 Key Information
19.5.4 SWOT Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Isothermal Nucleic Acid Amplification Technologies Market 2013-2018 (US$ million)
Exhibit 3: Global Isothermal Nucleic Acid Amplification Technologies Market Segmentation by Application
Exhibit 4: Global Isothermal Nucleic Acid Amplification Technologies Market 2013 (Percentage)
Exhibit 5: Global INAAT Market for Infectious Disease Diagnostics 2013-2018 (US$ million)
Exhibit 6: Global INAAT Market for Blood Screening 2013-2018 (US$ million)
Exhibit 7: Global INAAT Market for Laboratory Research 2013-2018 (US$ million)
Exhibit 8: Global INAAT Market for Cancer Research 2013-2018 (US$ million)
Exhibit 9: Global Isothermal Nucleic Acid Amplification Technologies Market by Applications 2013-2018 (US$ million)
Exhibit 10: Global Isothermal Nucleic Acid Amplification Technologies Market by Applications 2013-2018
Exhibit 11: Global Isothermal Nucleic Acid Amplification Technologies Market Segmentation by Technology
Exhibit 12: Global Isothermal Nucleic Acid Amplification Technologies Market by Application 2013
Exhibit 13: Isothermal Nucleic Acid Amplification Technologies Market in the Americas 2013-2018 (US$ million)
Exhibit 14: Isothermal Nucleic Acid Amplification Technologies Market in the EMEA 2013-2018 (US$ million)
Exhibit 15: Isothermal Nucleic Acid Amplification Technologies Market in the APAC 2013-2018 (US$ million)
Exhibit 16: Global Isothermal Nucleic Acid Amplification Technologies Technologies by Geography 2013-2018 (US$ million)
Exhibit 17: Global Isothermal Nucleic Acid Amplification Technologies Market by Geography 2013-2018
Exhibit 18: Business Segmentation of Hologic Inc.
Exhibit 19: Business Segmentation of Novartis International AG
Exhibit 20: Business Segmentation of Becton, Dickinson and Co.

Commenting on the report, an analyst from the team said: “The Molecular Diagnostics industry is experiencing a rapid shift toward an increase in the process automation and integration of sample analysis in single miniaturized devices. Miniaturization offers scope for reduced sample volume, enabling the end-user to automate and analyze the sample. Among all the diagnostic methods, nucleic acid testing remains the method with the most potential for conducting analysis in miniaturized devices. Although PCR is one of the standard techniques for conducting amplification reaction, the method is quite complex due to the need for repeated thermo cycling and cooling, and it consumes more energy in the process. As an alternative to PCR, isothermal nucleic amplification circumvents the need for repeated denaturation and cooling as the amplification reaction occurs under isothermal conditions. This greatly aids in the design of microfluidic chips for conducting molecular diagnostics. Most of these microfluidic devices adopting isothermal nucleic acid amplification methods are in the R&D phase. It is expected that the increase in miniaturization of nucleic acid-based diagnostics will boost the growth of the market.”

According to the report, one of the major drivers in this market is the technological advancements. Isothermal amplification-based technologies and their variants are being developed to address the diagnosis of many infectious disease- causing pathogens. Based on the mechanisms of the strand displacement properties of DNA polymerases, helicases, and other catalytic factors, many isothermal amplification methods have been developed.

Further, the report states that one of the major challenges in this market is the intense competition from PCR-based diagnostics. PCR-based diagnostics still remains the gold standard method for the amplification of nucleic acids owing to the popularity and wide range of product manufacturers.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

- Becton
- Dickson and Co.
- bioMerieux S.A.
- Hologic Inc.
- Novartis International AG.
- Quidel Corp.
- Alere Inc.
- Axxin Pvt Ltd.
- Eiken Chemical Co. Ltd.
- Great Basin Corp.
- Lucigen Corp.
- Meridian Bioscience Inc.
- New England Biolabs Inc.
- and Optigene Ltd.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos